Last Updated: August 10, 2026

ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE Drug Patent Profile

Name: ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Acetaminophen And Pentazocine Hydrochloride, and what generic alternatives are available?

Acetaminophen And Pentazocine Hydrochloride is a drug marketed by Gavis Pharms and Watson Labs and is included in two NDAs.

The generic ingredient in ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE?
What are the global sales for ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE?
What is Average Wholesale Price for ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE?

Summary for ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE

US Patents:	0
Applicants:	2
NDAs:	2
DailyMed Link:	ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE at DailyMed

Drug patent expirations by year for ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE

US Patents and Regulatory Information for ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gavis Pharms	ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE	acetaminophen; pentazocine hydrochloride	TABLET;ORAL	076202-001	Aug 2, 2002		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE	acetaminophen; pentazocine hydrochloride	TABLET;ORAL	074699-001	Mar 24, 2000		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.